Symposium
   
 


8th INTERNATIONAL SYMPOSIUM ON TARGETED ANTICANCER THERAPIES

Bethesda, MD, USA, March 4-6, 2010

 
     
 

Sponsors & exhibitors

TAT 2010 is supported by educational grants provided by:


Amgen
ArQule
Bristol-Myers Squibb
Celgene
ImClone Systems *
Lilly USA, LLC **
OSI Oncology

* a wholly-owned subsidiary of Eli Lilly and Company; for further information concerning ImClone Systems grant funding visit www.imclonegrantoffice.com.
** for further information concerning Lilly grant funding visit www.lillygrantoffice.com.


Corporate sponsorship:


Scholarship grants:

NCI Center for Cancer Research
Pfizer Oncology


TAT 2010 homepage

Organization & partners

Committees

Program (n.a.)

CME

Registration (n.a.)
Abstract submission (n.a.)
Presenters’ guidance (n.a.)
Scholarships (n.a.)
MDICT Task Force
Venue (n.a.)
Travel and Visa (n.a.)
Hotel reservation (n.a.)
Next meeting (n.a.)
Contact